[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370344-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-370344-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","association-of-radiotherapy-with-secondary-pelvic-cancers-in-male-patients-with-rectal-cancer","Association of radiotherapy with secondary pelvic cancers in male patients with rectal cancer","","Purpose: Explore the risk of secondary prostate cancer (SPC) and secondary bladder cancer (SBC) in male rectal cancer patients after radiotherapy (RT) and evaluate survival outcomes. Methods: A large population-based cohort from nine SEER registries (1973–2015) compared RT recipients vs no-RT, using Fine-Gray competing risks and Poisson regression. Results: RT was linked to lower SPC risk but higher SBC risk; for SPC patients, the no-RT group showed better 10-year overall and cancer-specific survival. Conclusion: RT decreases SPC risk but increases SBC risk; SBC and SPC monitoring after treatment is important.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/association-of-radiotherapy-with-secondary-pelvic-cancers-in-male-patients-with-rectal-cancer/370344/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/association-of-radiotherapy-with-secondary-pelvic-cancers-in-male-patients-with-rectal-cancer/370344.png","ImageObject",300,407,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study purpose regarding secondary cancers after radiotherapy?","Question",{"text":63,"@type":64},"To assess the risk of secondary prostate cancer and secondary bladder cancer in male rectal cancer patients after RT and to evaluate associated survival outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was RT exposure compared with no-RT in the methods?",{"text":68,"@type":64},"The study compared men who received surgery with adjuvant external-beam RT versus those who did not receive RT, using competing risk regression and survival analyses.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main findings about SPC and SBC risk?",{"text":72,"@type":64},"RT was associated with a lower adjusted hazard for SPC but a higher adjusted hazard for SBC in the competing risk analysis.",{"name":74,"@type":61,"acceptedAnswer":75},"How did survival differ for SPC patients between the RT and no-RT groups?",{"text":76,"@type":64},"For SPC patients, the no-RT group showed better 10-year overall survival and cancer-specific survival than the RT group.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},370344,1790219644,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","International Journal of Colorectal Disease (2025) 40:65  \n[https://doi.org/10.1007/s00384-025-04840-x](https://doi.org/10.1007/s00384-025-04840-x)  \nAssociation of radiotherapy with secondary pelvic cancers in male patients with rectal cancer  \nLei Liu1 · Shanglong Liu1 · Xiaomin Xia2 · Longbo Zheng1 · Xianxiang Zhang1 · Jilin Hu1 · Yiheng Ju1 · Yuan Gao1 · Yun Lu1  \nAccepted: 16 February 2025 © The Author(s) 2025  \nAbstract  \nPurpose We aimed to explore the risk of secondary prostate cancer (SPC) and secondary bladder cancer (SBC) in male rectal cancer (RC) patients after radiotherapy (RT) and to assess survival outcomes.  \nMethods This large population-based study included men with RC from nine registries in the Surveillance, Epidemiology, and End Results (SEER) database between 1973 and 2015. Fine-Gray competing risks and Poisson regression were used to assess the RT-related risk of SPC and SBC in patients who received RT versus those who did not (NRT) .  \nResults After exclusion, 28,886 RC patients were included in further analysis, including 9763 RT-treated patients (33.8%) and 19,123 patients not treated with RT (66.2%) . In competing risk regression analysis, RT was associated with a low risk of developing SPC (adjusted HR = 0.67; 95% CI = 0.64–0.82; P \u003C 0.001) and with a high risk of developing SBC (adjusted HR = 1.44; 95% CI = 1.15–1.80; P = 0.001). In the survival analysis of SPC patients, the NRT group exhibited better 10-year OS and CSS than the RT group (OS: HR = 0.52; 95% CI = 0.43–0.64; P \u003C 0.001; CSS: HR = 0.39; 95% CI = 0.26–0.56; P \u003C 0 .001) .  \nConclusion Male rectal cancer patients receiving RT had a decreased risk of SPC and an increased risk of SBC, and the prognosis of SPC patients in the RT group was worse compared to that of the NRT group. Follow-up and monitoring of SBC and SPC should not be ignored.  \nKeywords Rectal cancer · Radiotherapy · Secondary prostate cancer · Secondary bladder cancer · Incidence · Survival outcomes  \nIntroduction  \nRadiotherapy (RT) plays an important role in the regional control of locally advanced rectal cancer (RC), and several large prospective randomized controlled trials have demonstrated its positive role [1–3] . The National  \nLei Liu and Shanglong Liu have contributed equally to this work.  \n* Yuan Gao [gaoyuan@qdu.edu.cn](gaoyuan@qdu.edu.cn)  \n* Yun Lu[luyun@qdu.edu.cn](luyun@qdu.edu.cn)  \n1 Department of Gastrointestinal Surgery, Affiliated Hospital of Qingdao University, 266003 Qingdao, China  \n2 Department of Prosthodontics, Affiliated Hospital of Qingdao University, 266003 Qingdao, China  \nComprehensive Cancer Network guidelines recommend local RT as an integral part of RC treatment for patients with stage T3 or T4, patients with stage N1 or N2, and patients with incomplete resection [4] . Although RT can significantly improve local control rates, it does not improve the overall survival (OS) of patients [1, 5] . In this situation, it is crucial to correctly evaluate the extent of all possible adverse events. Conventional treatment in the USA consists of posterior pelvic irradiation of approximately 45 Gy, usually supplemented by additional additive irradiation to the tumor or resection bed [6 , 7] . The other organs of the pelvis inevitably receive a substantial radiation dose, which has implications for the development of secondary pelvis cancers in RC survivors [8] .  \nAlthough several current studies have evaluated the effect of RT on the occurrence of secondary pelvis cancers, none of them considered sex differences [9–11] .  \nDue to the differences in the pelvic structure of male and female RC patients, the effect of RT on secondary pelvis cancer is not the same. The uterus and prostate are organs unique to males and females, with different anatomical locations as well as different effects of RT. RT for RC has been found to increase the risk of uterine cancer in women but decrease the risk of secondary prostate cancer (SPC) in men in some current studies","cbCaijw8b3LqtsMs","https://ap.wps.com/l/cbCaijw8b3LqtsMs","pdf",1723421,11,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction\n# Materials and methods\n## Data source and patient selection\n## Treatment grouping\n# Results\n# Discussion","[{\"question\":\"What was the study purpose regarding secondary cancers after radiotherapy?\",\"answer\":\"To assess the risk of secondary prostate cancer and secondary bladder cancer in male rectal cancer patients after RT and to evaluate associated survival outcomes.\"},{\"question\":\"How was RT exposure compared with no-RT in the methods?\",\"answer\":\"The study compared men who received surgery with adjuvant external-beam RT versus those who did not receive RT, using competing risk regression and survival analyses.\"},{\"question\":\"What were the main findings about SPC and SBC risk?\",\"answer\":\"RT was associated with a lower adjusted hazard for SPC but a higher adjusted hazard for SBC in the competing risk analysis.\"},{\"question\":\"How did survival differ for SPC patients between the RT and no-RT groups?\",\"answer\":\"For SPC patients, the no-RT group showed better 10-year overall survival and cancer-specific survival than the RT group.\"}]","Association of radiotherapy with secondary pelvic cancers in male patients with rectal cancer | PDF",1790188134,28,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6f47e5f0c57c8463730b98461421eb0.webp",983,1305,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4586d97e51e071c3dd1344ba5614432b.webp",982,1304,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5afb218b1b6bbe6e2c70dfe0b9371343.webp",981,1303,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38929d551e4f21ea8229f8956fa1679e.webp",980,1301]